H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTUTE, INC
Tampa, FL US
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTUTE, INC Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20110059137 | CHEMOKINE GENE-MODIFIED CELLS FOR CANCER IMMUNOTHERAPY - Described herein are methods of cancer immunotherapy, particularly compositions comprising genetically-modified cells that express macrophage colony stimulating factor (GM-CSF), CD40 ligand (CD40L), and chemokine C—C motif ligand 21 (CCL21), wherein the population of cells comprises bystander cells and target cancer cells, and methods of making these compositions and treating cancer using these compositions. | 03-10-2011 |